Itopride is a prokinetic drug used to treat functional dyspepsia and other gastrointestinal conditions by increasing gastrointestinal motility. Unlike similar drugs, it does not act by inhibiting dopamine. Itopride is approved for use in many countries but not the United States or United Kingdom. Studies show itopride significantly improves symptoms of functional dyspepsia and motility disorders. Common side effects include abdominal pain and diarrhea.
Itopride is a prokinetic drug used to treat functional dyspepsia and other gastrointestinal conditions by increasing gastrointestinal motility. Unlike similar drugs, it does not act by inhibiting dopamine. Itopride is approved for use in many countries but not the United States or United Kingdom. Studies show itopride significantly improves symptoms of functional dyspepsia and motility disorders. Common side effects include abdominal pain and diarrhea.
Itopride is a prokinetic drug used to treat functional dyspepsia and other gastrointestinal conditions by increasing gastrointestinal motility. Unlike similar drugs, it does not act by inhibiting dopamine. Itopride is approved for use in many countries but not the United States or United Kingdom. Studies show itopride significantly improves symptoms of functional dyspepsia and motility disorders. Common side effects include abdominal pain and diarrhea.
Itopride is a prokinetic drug used to treat functional dyspepsia and other gastrointestinal conditions by increasing gastrointestinal motility. Unlike similar drugs, it does not act by inhibiting dopamine. Itopride is approved for use in many countries but not the United States or United Kingdom. Studies show itopride significantly improves symptoms of functional dyspepsia and motility disorders. Common side effects include abdominal pain and diarrhea.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 2
Itopride
Itopride (INN, trade name Ganaton) is a prokinetic benzamide derivative
unlike metoclopramide or domperidone. These drugs inhibit dopamine and have a gastrokinetic effect. [1] Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions. Itopride is not currently approved by the U.S. Food and Drug Administration (FDA) for use in the United States, nor is it yet approved in the United Kingdom. This may explain the apparent lack of patient information available in English compared to other similar classes of medication. Clinical use A blister package of Ganaton (Itopride) 50 mg tablets intended for distribution in the Slovak Republic. Typically, itopride is indicated in the treatment of GI symptoms caused by reduced GI motility: dyspepsia of a non-ulcer/dysmotility type (gastric "fullness", discomfort, and possible pain) Delayed gastric emptying anorexia heartburn regurgitation bloating nausea and vomiting other possible gastric, prolactin, or dopamine related conditions Itopride is typically taken three times a day. The dose is usually taken on an empty stomach about an hour before meals. However, the dosage and details of administration may vary depending on the patients age, symptoms, and other factors. Itopride was shown to significantly improve symptoms in patients with functional dyspepsia and motility disorders in placebo-controlled trials. These studies concluded that the reduction in the severity of symptoms of functional dyspepsia after 8 weeks of treatment with itopride indicated that itopride was significantly superior to placebo and that itopride yielded a greater rate of response than placebo in significantly reducing pain and fullness. Contraindications and precautions Itopride is a relatively new drug and it is not currently approved for normal prescribed use nor OTC use in either the US nor the UK. However, this does not necessarily indicate that itopride is not effective or safe. Patients taking itopride should report any side-effects to their treating physician. Itopride is contraindicated in hypersensitivity to itopride or benzamides; lactation, GI hemorrhage, obstruction or perforation. Itopride may not be indicated for those suffering from Parkinson's disease or other conditions involving dopamine regulation issues. Itopride should be used with special caution in the young and the elderly. Little information is available at this time regarding the safe use of itopride during pregnancy. Adverse drug reactions The most common side-effects of itopride include mild to moderate abdominal pain and diarrhoea. Some other side effects that may occur include: rash, giddiness, exhaustion, back or chest pain, increased salivation, constipation, headache, sleeping disorders, dizziness, galactorrhea, and gynecomastia. Other side effects may also be present. Leukopenia, a reduction in the normal level of white blood cells, can be a potentially life-threatening reaction to itopride. Central nervous system adverse effects do not tend to occur due to poor penetration across the blood brain barrier, although a slight raising of prolactin levels may occur. Raising of prolactin levels is more common with high dose regimes of itopride. Mechanism of action Itopride increases acetylcholine concentrations by inhibiting dopamine D2 receptors and acetylcholinesterase. Higher acetylcholine increases GI peristalsis, increases the lower esophageal sphincter pressure, stimulates gastric motility, accelerates gastric emptying, and improves gastro-duodenal coordination.